Company Filing History:
Years Active: 1998-2001
Title: Dana Johnson: Innovator in Erythropoietin Research
Introduction
Dana Johnson is a notable inventor based in Upper Black Eddy, Pennsylvania. He has made significant contributions to the field of biochemistry, particularly in the study of erythropoietin receptor binding proteins. With a total of 2 patents, his work has implications for drug design and therapeutic applications.
Latest Patents
Dana Johnson's latest patents include innovative methods for identifying erythropoietin receptor binding proteins. One of his patents details the expression and overproduction of the extracellular domain of the human erythropoietin receptor, known as EPO binding protein (EBP). This method allows for the efficient recovery of purified EBP, which quantitatively binds EPO and competes with membrane-associated EPO receptors. His research also includes the development of a fusion protein, EBP-Ig, which serves as a dimerization template useful in drug design and discovery. Additionally, he has patented compounds and peptides that activate the erythropoietin receptor, showcasing his expertise in this specialized area.
Career Highlights
Throughout his career, Dana Johnson has worked with prominent companies such as Affymax Technologies and Ortho Pharmaceutical Corporation. His experience in these organizations has contributed to his innovative research and development in the field of biochemistry.
Collaborations
Dana has collaborated with notable colleagues, including Linda K. Jolliffe and Nicholas C. Wrighton. These partnerships have likely enhanced his research capabilities and broadened the impact of his work.
Conclusion
Dana Johnson's contributions to erythropoietin research and his innovative patents highlight his role as a significant inventor in the field. His work continues to influence drug design and therapeutic applications, showcasing the importance of his research in advancing medical science.